Belantamab Mafodotin, Bortezomib, and Dexamethasone Vs Daratumumab, Bortezomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Overall Survival Analysis and Updated Eff... by Hungria, Vania, Robak, Pawel, Hus, Marek, Zherebtsova, Vera, Ward, Christopher, Ho, Phoebe Joy, Hajek, Roman, Kim, Kihyun, Grosicki, Sebastian, Sia, Hanlon, Bryant, Adam, Lacerda, Marcelo Pitombeira de, Martinez, Gracia Aparecida, Sureda Balarí, Anna Maria, Sandhu, Irwindeep, Cerchione, Claudio, Ganly, Peter, Dimopoulos, Meletios, Fu, Chengcheng, Garg, Mamta, Abdallah, Al-Ola, Gatt, Moshe E, Oriol, Albert, Cavo, Michele, Rifkin, Robert, Fujisaki, Tomoaki, Mielnik, Michał, Pirooz, Nick, Lee, Joe, McKeown, Astrid, Rogers, Rachel, Baig, Hena, Eccersley, Lydia, Roy-Ghanta, Sumita, Mateos, Maria Victoria

Get full text

MM-557 DREAMM-7 Update: Subgroup Analyses From a Phase 3 Trial of Belantamab Mafodotin (Belamaf) + Bortezomib and Dexamethasone (BVd) vs Daratumumab, Bortezomib, and Dexamethasone... by Victoria, Maria, Robak, Pawel, Hus, Marek, Fu, ChengCheng, Zherebtsova, Vera, Ward, Christopher, Ho, P. Joy, de Almeida, Ana Carolina, Hajek, Roman, Kim, Kihyun, Dimopoulos, Meletios, Cerchione, Claudio, Pirooz, Nick, McKeown, Astrid, Kazeem, Benga, Baig, Hena, Eccersley, Lydia, Roy-Ghanta, Sumita, Opalinska, Joanna, Hungria, Vania

Get full text

MM-542 Patient-Reported Outcomes From the DREAMM-7 Randomized Phase 3 Study Comparing Belantamab Mafodotin (Belamaf), Bortezomib, and Dexamethasone vs Daratumumab Bortezomib, and D... by Hungria, Vania, Robak, Pawel, Hus, Marek, Fu, ChengCheng, Zherebtsova, Vera, Ward, Christopher, de Almeida, Ana Carolina, Ho, P. Joy, Hajek, Roman, Cerchione, Claudio, Pirooz, Nick, McKeown, Astrid, Baig, Hena, Eccersley, Lydia, Pompilus, Farrah, McNamara, Simon, Paul Lin, Chee, Roy-Ghanta, Sumita, Opalinska, Joanna, Victoria, Maria

Get full text

P-396 Characterization and Management of Ocular Events in Patients (Pts) Treated With Belantamab Mafodotin (Belamaf) Plus Bortezomib and Dexamethasone (BVd) in the DREAMM-7 Study by Hungria, Vania T.M., Robak, Pawel, Hus, Marek, Fu, Chengcheng, Zherebtsova, Vera, Ward, Christopher, Ho, P. Joy, Hájek, Roman, Kim, Kihyun, de Lacerda, Marcelo Pitombeira, Aparecida-Martinez, Gracia, Dimopoulos, Meletios, Cerchione, Claudio, Pirooz, Nick, McKeown, Astrid, Rogers, Rachel, Kazeem, Benga, Wang, Zhaohui, Baig, Hena, Eccersley, Lydia, Roy-Ghanta, Sumita, Opalinska, Joanna, Manteca, María-Victoria Mateos

Get full text

DREAMM-7 Update: Subgroup Analyses From a Phase 3 Trial of Belantamab Mafodotin (Belamaf) + Bortezomib and Dexamethasone (BVd) vs Daratumumab, Bortezomib, and Dexamethasone (DVd) i... by Mateos, Maria Victoria, Robak, Pawel, Hus, Marek, Fu, ChengCheng, Zherebtsova, Vera, Ward, Christopher, Joy Ho, P., Carolina de Almeida, Ana, Hajek, Roman, Kim, Kihyun, Dimopoulos, Meletios, Cerchione, Claudio, Pirooz, Nick, McKeown, Astrid, Kazeem, Benga, Baig, Hena, Eccersley, Lydia, Roy-Ghanta, Sumita, Opalinska, Joanna, Hungria, Vania

Get full text

Patient-Reported Outcomes From the DREAMM-7 Randomized Phase 3 Study Comparing Belantamab Mafodotin (Belamaf), Bortezomib, and Dexamethasone vs Daratumumab, Bortezomib, and Dexamet... by Hungria, Vania, Robak, Pawel, Hus, Marek, Fu, ChengCheng, Zherebtsova, Vera, Ward, Christopher, Carolina de Almeida, Ana, Joy Ho, P., Hajek, Roman, Cerchione, Claudio, Pirooz, Nick, McKeown, Astrid, Baig, Hena, Eccersley, Lydia, Pompilus, Farrah, McNamara, Simon, Paul Lin, Chee, Roy-Ghanta, Sumita, Opalinska, Joanna, Victoria Mateos, Maria

Get full text

A Phase II Trial Comparison of Once Versus Twice Weekly Bortezomib in CYBORD Chemotherapy for Newly Diagnosed Myeloma: Identical High Response Rates and Less Toxicity by Reeder, Craig B., Reece, Donna E., Kukreti, Vishal, Mikhael, Joseph R., Chen, Christine, Trudel, Suzanne, Laumann, Kristina, Hentz, Joseph, Pirooz, Nick, Piza, Jg, Zepeda, Victor J Jimenez, Fonseca, Rafael, Bergsagel, P. Leif, Leis, Jose, Tiedemann, Rodger E., Stewart, A. Keith

Get full text